Manufacturing Expansion Novartis is expanding manufacturing capacity in North Carolina and RTP, signaling a push to scale oncology production. This creates opportunities for contract development and manufacturing, process optimization, and supply-chain services to support increased output.

Portfolio Focus A portfolio focused on five key cancer areas with multiple compounds in development drives ongoing needs for clinical trial support, companion diagnostics partnerships, and market access data programs to accelerate adoption.

Digital & Data With a mature data and security stack, there is appetite for advanced analytics, cloud integration, and interoperability solutions to improve R&D efficiency, manufacturing quality, and patient data protection.

Partnerships & Innovation Active collaborations with academia and industry indicate opportunities to co-develop platforms, accelerate trial recruitment, and deploy digital health and AI-enabled discovery across oncology programs.

Global Market Growth Expansion into India and Australia and New Zealand, along with U.S. manufacturing growth, suggests opportunities to tailor commercialization, build local clinical support, and establish distribution partnerships for new and existing therapies.